Published in Aliment Pharmacol Ther on May 13, 2013
The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease. Am J Gastroenterol (2015) 2.51
Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease. J Clin Gastroenterol (2014) 2.11
Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome. World J Gastroenterol (2014) 0.93
IBS-like symptoms in patients with ulcerative colitis. Clin Exp Gastroenterol (2015) 0.86
Gastrointestinal motility disorders in inflammatory bowel diseases. World J Gastroenterol (2014) 0.84
Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place. Intest Res (2016) 0.82
Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? Therap Adv Gastroenterol (2016) 0.81
IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol (2016) 0.79
The analysis of factors associated with progression of isolated terminal ileal lesions. PLoS One (2014) 0.79
Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol (2016) 0.78
Perianal disease is associated with psychiatric co-morbidity in Crohn's disease in remission. Int J Colorectal Dis (2014) 0.77
Letter: the role of sub-clinical inflammation and TRPV1 in the development of IBS-like symptoms in ulcerative colitis in remission. Aliment Pharmacol Ther (2013) 0.77
Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res (2016) 0.77
Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease. Dig Dis Sci (2015) 0.76
Implementable strategies and exploratory considerations to reduce costs associated with anti-TNF therapy in inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.75
Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls. BMC Gastroenterol (2016) 0.75
Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide. Inflamm Bowel Dis (2017) 0.75
Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World J Gastrointest Pharmacol Ther (2016) 0.75
Commentary: symptoms of irritable bowel syndrome in patients with inflammatory bowel disease--organic disease or diseased organ? Aliment Pharmacol Ther (2013) 0.75
Symptom clusters in adults with inflammatory bowel disease. Res Nurs Health (2017) 0.75
Transgenic plant aequorin reports the effects of touch and cold-shock and elicitors on cytoplasmic calcium. Nature (1991) 6.73
Shared decision making: developing the OPTION scale for measuring patient involvement. Qual Saf Health Care (2003) 4.28
Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ (2009) 3.95
Public attitudes towards the use of primary care patient record data in medical research without consent: a qualitative study. J Med Ethics (2004) 2.70
The effectiveness of one-to-one risk communication interventions in health care: a systematic review. Med Decis Making (2000) 2.68
Association of lactose sensitivity with inflammatory bowel disease--demonstrated by analysis of genetic polymorphism, breath gases and symptoms. Aliment Pharmacol Ther (2011) 2.61
Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev (2005) 2.57
Differences in sexual risk behaviour between young men and women travelling abroad from the UK. Lancet (1998) 2.52
Patient-based outcome results from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice. Fam Pract (2004) 2.36
Achieving involvement: process outcomes from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice. Fam Pract (2004) 2.14
Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines. Eur Respir J (2011) 2.13
Immunoaffinity purification of human complement component C9 using monoclonal antibodies. J Immunol Methods (1983) 2.11
Quantifying the 'hidden' lactose in drugs used for the treatment of gastrointestinal conditions. Aliment Pharmacol Ther (2009) 2.06
Imaging calcium dynamics in living plants using semi-synthetic recombinant aequorins. J Cell Biol (1993) 2.00
Stimulation of Ca2+-dependent chemiluminescence in rat polymorphonuclear leucocytes by polystyrene beads and the non-lytic action of complement. Immunology (1981) 1.79
Personalised risk communication for informed decision making about entering screening programs. Cochrane Database Syst Rev (2003) 1.77
Personalised risk communication for informed decision making about taking screening tests. Cochrane Database Syst Rev (2006) 1.73
Interventions before consultations for helping patients address their information needs. Cochrane Database Syst Rev (2007) 1.69
Chemiluminescence as an analytical tool in cell biology and medicine. Methods Biochem Anal (1985) 1.66
Measurement of changes in cytoplasmic free CA2+ in fused cell hybrids. Nature (1982) 1.65
Chimeric green fluorescent protein-aequorin as bioluminescent Ca2+ reporters at the single-cell level. Proc Natl Acad Sci U S A (2000) 1.65
Effects of mechanical signaling on plant cell cytosolic calcium. Proc Natl Acad Sci U S A (1995) 1.63
Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) 1.60
Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attack. Nature (1985) 1.59
Palliative care in hospital, hospice, at home: results from a systematic review. Ann Oncol (2002) 1.52
MAGNEsium Trial In Children (MAGNETIC): a randomised, placebo-controlled trial and economic evaluation of nebulised magnesium sulphate in acute severe asthma in children. Health Technol Assess (2013) 1.52
Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature (1989) 1.49
The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium. Biochem J (1985) 1.49
Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. Am J Psychiatry (2001) 1.47
Two distinct mechanisms for stimulation of oxygen-radical production by polymorphonuclear leucocytes. Biochem J (1983) 1.44
Direct measurement of the increase in intracellular free calcium ion concentration in response to the action of complement. Biochem J (1981) 1.43
Enzymatic activity of albumin shown by coelenterazine chemiluminescence. Luminescence (2012) 1.43
Differential regulation of nuclear and cytosolic Ca2+ in HeLa cells. J Biol Chem (1996) 1.42
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results. J Neurol Neurosurg Psychiatry (1987) 1.42
When sugar is not so sweet. Lancet (2000) 1.40
Antibiotic prescribing for discoloured sputum in acute cough/lower respiratory tract infection. Eur Respir J (2011) 1.39
Measurement of intracellular calcium ions and oxygen radicals in polymorphonuclear leucocyte-erythrocyte 'ghost' hybrids. J Physiol (1983) 1.39
A cluster randomised controlled trial of a manualised cognitive behavioural anger management intervention delivered by supervised lay therapists to people with intellectual disabilities. Health Technol Assess (2013) 1.38
Inhibition of complement-induced [14C]sucrose release by intracellular and extracellular monoclonal antibodies to C9: evidence that C9 is a transmembrane protein. Biochem Biophys Res Commun (1984) 1.33
Efficient literature searching in diffuse topics: lessons from a systematic review of research on communicating risk to patients in primary care. Health Libr Rev (1999) 1.32
Interventions to improve risk communication in clinical genetics: systematic review. Patient Educ Couns (2008) 1.31
Targeting aequorin to the endoplasmic reticulum of living cells. Biochem Biophys Res Commun (1992) 1.31
Oxidase activation in individual neutrophils is dependent on the onset and magnitude of the Ca2+ signal. Cell Calcium (1991) 1.30
A mechanism for the insertion of complement component C9 into target membranes. Mol Immunol (1986) 1.30
Levels of mental health problems among UK emergency ambulance workers. Emerg Med J (2004) 1.29
Comparative aspects of the calcium-sensitive photoproteins aequorin and obelin. Biochim Biophys Acta (1975) 1.27
BION system for distributed neural prosthetic interfaces. Med Eng Phys (2001) 1.26
Intracellular Ca2+ and cell injury: a paradoxical role of Ca2+ in complement membrane attack. Cell Calcium (1986) 1.25
Extraction, partial purification and properties of obelin, the calcium-activated luminescent protein from the hydroid Obelia geniculata. Biochem J (1974) 1.23
Assembly of chimeric connexin-aequorin proteins into functional gap junction channels. Reporting intracellular and plasma membrane calcium environments. J Biol Chem (1998) 1.22
Nuclear localisation of calreticulin in vivo is enhanced by its interaction with glucocorticoid receptors. FEBS Lett (1997) 1.21
Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J (2000) 1.20
Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation. J Neuroimmunol (1989) 1.20
Is intracellular Ca2+ the trigger for oxygen radical production by polymorphonuclear leucocytes? Cell Calcium (1984) 1.20
Prediction of albumin excretion rate from albumin-to-creatinine ratio. Diabetes Care (1999) 1.19
Systemic lactose intolerance: a new perspective on an old problem. Postgrad Med J (2005) 1.18
Engineering the CA(2+)-activated photoprotein aequorin with reduced affinity for calcium. Biochem Biophys Res Commun (1992) 1.17
Rapid increase in intracellular free Ca2+ induced by antibody plus complement. FEBS Lett (1979) 1.16
Inhibition by adenosine of reactive oxygen metabolite production by human polymorphonuclear leucocytes. Biochem J (1985) 1.15
Changes in free calcium in the endoplasmic reticulum of living cells detected using targeted aequorin. Anal Biochem (1994) 1.15
Localized superoxide release by neutrophils can be provoked by a cytosolic calcium 'cloud'. Immunology (1991) 1.14
An assessment of the role of intracellular free Ca2+ in E. coli. Biochimie (2000) 1.14
The effects of glucagon and insulin on adenosine 3':5'-cyclic monophosphate concentrations in an organ culture of mature rat liver. Biochem J (1973) 1.13
Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies. J Neurol Sci (1989) 1.13
Albumin inhibits human polymorphonuclear leucocyte luminol-dependent chemiluminescence: evidence for oxygen radical scavenging. Br J Exp Pathol (1984) 1.12
Newborn screening for Duchenne muscular dystrophy: a psychosocial study. Arch Dis Child Fetal Neonatal Ed (2002) 1.09
Requirement of the C-terminal proline residue for stability of the Ca(2+)-activated photoprotein aequorin. Biochem J (1993) 1.09
Decrease in apparent Km for oxygen after stimulation of respiration of rat polymorphonuclear leukocytes. FEBS Lett (1983) 1.08
Immunoradiometric assay for human complement component C9 utilising monoclonal antibodies. Clin Chim Acta (1983) 1.08
Current evidence suggests independent regulation of nuclear calcium. Cell Calcium (1998) 1.07
Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol Appl Neurobiol (1989) 1.05
Dissociation of store release from transmembrane influx of calcium in human neutrophils. FEBS Lett (1992) 1.05
Slow changes in cytosolic free Ca2+ in Escherichia coli highlight two putative influx mechanisms in response to changes in extracellular calcium. Cell Calcium (1999) 1.03
Free calcium transients in chemotactic and non-chemotactic strains of Escherichia coli determined by using recombinant aequorin. Biochem J (1995) 1.03
Oxygen-radical production during inflammation may be limited by oxygen concentration. Biochem J (1984) 1.03
Maintenance of viable cells in an organ culture of mature rat liver. Exp Cell Res (1971) 1.02
Acridinium esters as high-specific-activity labels in immunoassay. Clin Chem (1983) 1.00
A children's acute respiratory illness scale (CARIFS) predicted functional severity and family burden. J Clin Epidemiol (2004) 1.00
Are smokers with acute cough in primary care prescribed antibiotics more often, and to what benefit? An observational study in 13 European countries. Eur Respir J (2009) 0.99
Permeability to calcium of pigeon erythrocyte 'ghosts' studied by using the calcium-activated luminescent protein, obelin. Biochem J (1975) 0.99
Immunolocalization of complement component C9 on necrotic and non-necrotic muscle fibres in myositis using monoclonal antibodies: a primary role of complement in autoimmune cell damage. Immunology (1984) 0.99
A literature and medicine special study module run by academics in general practice: two evaluations and the lessons learnt. Med Humanit (2004) 0.98
Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis. Lancet (1984) 0.98
Nucleoplasmin-targeted aequorin provides evidence for a nuclear calcium barrier. Exp Cell Res (1995) 0.97
2-Chloroadenosine inhibits complement-induced reactive oxygen metabolite production and recovery of human polymorphonuclear leucocytes attacked by complement. Biochem Biophys Res Commun (1985) 0.97
Judging the 'weight of evidence' in systematic reviews: introducing rigour into the qualitative overview stage by assessing Signal and Noise. J Eval Clin Pract (2000) 0.97
Inflammatory bowel disease and smoking--a review. Am J Gastroenterol (1998) 0.97
How death anxiety impacts nurses' caring for patients at the end of life: a review of literature. Open Nurs J (2013) 0.96
Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the alpha3 nicotinic acetylcholine receptor subunit. Gastroenterology (2001) 0.96
Intracellular free calcium as a pathogen in cell damage initiated by the immune system. Experientia (1981) 0.96
The membrane attack complex of complement induces permeability changes via thresholds in individual cells. Immunology (1987) 0.95
Communication skills of healthcare professionals in paediatric diabetes services. Diabet Med (2009) 0.95
Reversible injury of cultured rat oligodendrocytes by complement. Immunology (1989) 0.95
The ninth complement component in rheumatoid arthritis, Behçet's disease and other rheumatic diseases. Br J Rheumatol (1986) 0.95
Sendai virus causes a rise in intracellular free Ca2+ before cell fusion. Biochem J (1982) 0.95
Removal of twelve C-terminal amino acids from firefly luciferase abolishes activity. Biochem Biophys Res Commun (1990) 0.94
Induction of calreticulin expression in HeLa cells by depletion of the endoplasmic reticulum Ca2+ store and inhibition of N-linked glycosylation. Biochem J (1996) 0.94
The effect of intracellular calcium ions on adrenaline-stimulated adenosine 3':5'-cyclic monophosphate concentrations in pigeon erythrocytes, studied by using the ionophore A23187. Biochem J (1976) 0.94